OBJECTIVE: To further investigate the management and prognosis of primary urethral cancer in male.
METHODS: We treated 3 cases of primary urethral cancer from 2001 to 2011 and followed them up for recurrence and survival.
RESULTS: The 3 male patients all received adjuvant radiotherapy and/or chemotherapy, and 2 of them were treated by distal urethrectomy, while the other underwent no surgery. Follow-up visits revealed 2 cases of metastasis and 1 case of death.
CONCLUSION: Primary cancer of the male urethra is a rare malignancy with poor prognosis, for which radical resection is the main treatment method. Those in the relatively advanced stage can be treated by a combined method of surgery, radiotherapy and chemotherapy.
Written by:
Zhu XF, Zhang K, Jin J, Huang BW, Li S, Lin J. Are you the author?
Department of Urology, Peking University First Hospital, Beijing 100034, China.
Reference: Zhonghua Nan Ke Xue. 2012 Jul;18(7):615-8.
PubMed Abstract
PMID: 22994047
Article in Chinese.
UroToday.com Penile and Urethral Cancers Section
